Abstract
A 50-year-old man presented with a rapidly growing painless ulcer, over the back extending to the right flank (Fig. 38.1). He had no systemic symptoms, and no lymphadenopathy. He was not known to have any medical illness.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsBibliography
Aisenberg AC, Wilkes BM, Jacobson JO. The bcl-2 gene is rearranged in many diffuse B-cell lymphomas. Blood. 1988;71:969–72.
Azar HA, Jaffe ES, Berard CW, Callihan TR, Braylan RR, Cossman J, et al. Diffuse large cell lymphomas (reticulum cell sarcomas, histiocytic lymphomas). Correlation of morphologic features with functional markers. Cancer. 1980;46:1428–41.
Burg G, Kempf W, Cozzio A, et al. WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol. 2005;32(10):647–74.
Burg G, Kaudewitz P, Klepzig K, Przybilla B, Braun-Falco O. Cutaneous B-cell lymphoma. Dermatol Clin. 1985;3(4):689–704.
Chabner BA, Johnson RE, Young RC, Canellos GP, Hubbard SP, Johnson SK, et al. Sequential nonsurgical and surgical staging of non-Hodgkin’s lymphoma. Ann Intern Med. 1976;85:149–54.
Coiffier B, Brousse N, Peuchmaur M, Berger F, Gisselbrecht C, Bryon PA, et al. Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas. A prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d’Etude des Lymphomes Agressives). Ann Oncol. 1990;1:45–50.
Dalla-Favera R, Ye RH, Lo Coco F, Gaidano G, Lista F, Knowles DM, et al. Identification of genetic lesions associated with diffuse large-cell lymphoma. Ann Oncol. 1994;5:S55–60.
De Jong D, Van Gorp J, Sie-Go D, Van Heerde P. T-cell rich B-cell non-Hodgkins’s disease. Histopathology. 1996;28:15–24.
Fleming MD, Shahsafaei A, Dorfman DM. Absence of dendritic reticulum cell staining is helpful for distinguishing T-cell-rich B-cell lymphoma from lymphocyte predominance Hodgkin’s disease. Appl Immunohistochem. 1998;6:16–22.
Fraga M, Garcia-Riviero A, Sanchez-Verde L, Forteza J, Piris MA. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin’s lymphoma. Histopathology. 2002;41:216–29.
Franke S, Wlodarska I, Maes B, Vandenberghe P, Achten R, Hagemeijer A, et al. Comparative genomic hybridization pattern distinguishes T-cell/histiocyte-rich B-cell lymphoma from nodular lymphocyte predominance Hodgkin’s lymphoma. Am J Pathol. 2002;161:1861–7.
Hoefnagel JJ, Dijkman R, Basso K, et al. Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling. Blood. 2005;105:3671–8.
Lim MS, Beaty M, Sorbara L, Cheng RZ, Pittaluga S, Raffeld M, et al. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B-cells. Am J Surg Pathol. 2002;26:1458–66.
Lo Coco F, Ye BH, Lista F, Corradini P, Offit K, Knowles DM, et al. Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin’s lymphoma. Blood. 1994;83:1757–9.
Lukes RJ, Parker JW, Taylor CR, Tindle BH, Cramer AD, Lincoln TL. Immunologic approach to non-Hodgkin lymphomas and related leukemias. Analysis of the results of multiparameter studies of 425 cases. Semin Hematol. 1978;15:322–51.
Offit K, Lo Coco F, Louie DC, Parsa NZ, Leung D, Portlock C, et al. Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma. N Engl J Med. 1994;331:74–80.
Pileri SA, Dirnhofer S, Went PH, Ascani S, Sabattini E, Marafioti T, et al. Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification. Histopathology. 2002;41:482–509.
Rudiger T, Ott G, Ott MM, Muller-Deubert SM, Müller-Hermelink HK. Differential diagnosis between classic Hodgkin’s lymphoma, T-cell-rich B-cell lymphoma, and paragranuloma by paraffin immunohistochemistry. Am J Surg Pathol. 1998;22:1184–91.
Strauchen JA, Young RC, DeVita VT, Anderson T, Fantone JC, Berard CW. Clinical relevance of the histopathological subclassification of diffuse “histiocytic” lymphoma. N Engl J Med. 1978;299:1382–7.
Veronesi U, Musumeci R, Pizzetti F, Gennari L, Bonadonna G. The value of staging laparotomy in non-Hodgkin’s lymphomas (with emphasis on the histiocytic type). Cancer. 1974;33:446–59.
Warnke RA, Kim H, Fuks Z, Dorfman RE. The coexistence of nodular and diffuse patterns in nodular non-Hodgkin’s lymphomas. Significance and clinicopathologic correlation. Cancer. 1977;40:1229–33.
Warnke R, Miller R, Grogan T, Pederson M, Dilley J, Levy R. Immunologic phenotype in 30 patients with diffuse large-cell lymphoma. N Engl J Med. 1980;303:293–300.
Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768–85.
Woo DK, Jones CR, Vanoli-Storz MN, Kohler S, Reddy S, Advani R, et al. Prognostic factors in primary cutaneous anaplastic large cell lymphoma: characterization of clinical subset with worse outcome. Arch Dermatol. 2009;145(6):667–74.
Ye BH, Rao PH, Chaganti RSK, Dalla-Favera R. Cloning of bcl-6, the locus involved in chromosomal translocations affecting band 3q27 in B-cell lymphoma. Cancer Res. 1993;43:2732–5.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
El-Darouti, M.A. (2013). Ulceration in the Flank of a Middle-Aged Man. In: Challenging Cases in Dermatology. Springer, London. https://doi.org/10.1007/978-1-4471-4249-2_38
Download citation
DOI: https://doi.org/10.1007/978-1-4471-4249-2_38
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-4248-5
Online ISBN: 978-1-4471-4249-2
eBook Packages: MedicineMedicine (R0)